Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Brain Tumor Research and Treatment is Scopus-indexed (Q1, CiteScore 3.8). Published by The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology.
Checked against the index lists dated .
ISSN 2288-2405Verify ISSN ↗2288-2413Verify ISSN ↗
Publisher: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 137 / 597 | 77th | Q1 |
| Neurology (clinical) | 203 / 403 | 49th | Q3 |
| Oncology | 227 / 428 | 47th | Q3 |
| Cellular and Molecular Neuroscience | 75 / 102 | 26th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q1, CiteScore 3.8.
Brain Tumor Research and Treatment is Q1 in Surgery (rank 137 of 597), Q3 in Neurology (clinical) (rank 203 of 403) and Q3 in Oncology (rank 227 of 428), by CiteScore 2025. It is ranked in 4 subject areas in all.
Brain Tumor Research and Treatment is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 3.8, quartile Q1, 77th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.615, quartile Q2, with an H-index of 12.
Brain Tumor Research and Treatment is published by The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology. Its print ISSN is 2288-2405 and its online ISSN is 2288-2413.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Brain Tumor Research and Treatment has an h-index of 30 and a 2-year mean of 2.01 citations per paper (OpenAlex). Its Scopus CiteScore is 3.8, quartile Q1. On 2-year citations it ranks #122 of 585 Scopus journals in Surgery.
Brain Tumor Research and Treatment published 26 papers in 2025; its busiest recent year was 2022 with 40. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from South Korea (65.5%), United States (12.6%) and Pakistan (5.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.